Clinical trial paves way for “micro patch” vaccine delivery
Vaxxas’ micro-needle patch has potential to deliver enhanced immune response, quicker and at a lower dose
PLEASE NOTE: IMCRC closed at the end of 2022 and this website is for reference purposes only.
Vaxxas’ micro-needle patch has potential to deliver enhanced immune response, quicker and at a lower dose
Manufacturing research to increase the shelf-life of radiation drugs